PROX1 and gastric cancer: 858 patients were pooled from 6 studies and the meta-analysis indicates that PROX1 expression is not related to tumor metastases (M1 and M0) in GC (OR: 1.096, 95% CI 0.470–2.555, P = 0.763) (Fig. 7 and Additional file 1: Table S1).